Switzerland· 51830042

Reparil N, Gel

A preparations with salicylic acid derivatives product containing aescinum, diethylamini salicylas, registered in Switzerland by Verfora SA and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat D (Swissmedic)ATC M02AC

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedReparil N, GelATCM02ACREGISTER NO.51830042PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Aescinum, diethylamini salicylas is registered in 8 of 19 countries.

Countries holding a registration under ATC M02AC (preparations with salicylic acid derivatives), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose

Aescinum, diethylamini salicylas · ATC M02AC

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
aescinum, diethylamini salicylas
Manufacturer
Verfora SA
Country
Switzerland (CH)
ATC code
M02AC
ATC class
Preparations with salicylic acid derivatives
Swissmedic category
D
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680518300422
    100 g
    CHF 13.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/42cf5cb7-a59a-4fee-8d6d-c507fce06d0a
GET /v1/drugs/42cf5cb7-a59a-4fee-8d6d-c507fce06d0a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "aescinum 10 mg + diethylamini salicylas 50 mg",
  "valid_from": "2007-05-01",
  "limitations": null,
  "galenic_form": "Gel",
  "therapeutic_area": null,
  "sl_inclusion_date": "2007-05-01",
  "self_retention_pct": 10
}

See everything about aescinum, diethylamini salicylas.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.